Press release
September 8, 2026
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year
Sarepta Therapeutics, Inc. (SRPT)
Recipients include 20 individuals living with Duchenne and five siblings of individuals living with the condition Now in its ninth year, program has awarded more than 150 scholarships CAMBRIDGE, Mass. --(BUSINESS WIRE)--Sep. 8, 2026-- Sarepta Therapeutics, Inc.